Finance

Lists
COLL:NASDAQ
Collegium Pharmaceutical Inc
၂၂.၂၃ US$
-၁.၇၇%
(-၀.၄၀) 1D
၂၂.၂၃ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: စက် ၂၉, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for COLL...
Open
၂၂.၆၁ US$
High
၂၂.၉၂ US$
Low
၂၁.၆၂ US$
Mkt. cap
၇၂.၃၇ ကုဋေ
Avg. vol.
၈.၇၄ သိန်း
Volume
၁.၀၂ သန်း
P/E ratio
၁၈.၁၀
52-wk high
၅၀.၇၉ US$
52-wk low
၂၁.၆၂ US$
EPS
၁.၂၃ US$
Beta
၀.၇၂
Shares outstanding
၃.၂၆ ကုဋေ
No. of employees
၄၂၃
Open
၂၂.၆၁ US$
High
၂၂.၉၂ US$
Low
၂၁.၆၂ US$
Mkt. cap
၇၂.၃၇ ကုဋေ
Avg. vol.
၈.၇၄ သိန်း
Volume
၁.၀၂ သန်း
P/E ratio
၁၈.၁၀
52-wk high
၅၀.၇၉ US$
52-wk low
၂၁.၆၂ US$
EPS
၁.၂၃ US$
Beta
၀.၇၂
Shares outstanding
၃.၂၆ ကုဋေ
No. of employees
၄၂၃
News stories
From web sources and news partners
StockStory
StockStory
·
ပြီးခဲ့သည့် ၁ ရက်
3 Value Stocks That Fall Short
About Collegium Pharmaceutical Inc
CEO-
Employees၄၂၃
Founded၂၀၀၂
Headquarters-
Sector-
Analyst ratings
Based on 7 analysts giving stock ratings to COLL in the past 3 months
Strong buy
Buy
6
Hold
1
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for COLL in the last 3 months.
Highest
Current ၂၂.၂၃ US$
၆၀.၀၀ US$ (+၁၆၉.၉၁%)
Average
၄၈.၇၁ US$ (+၁၁၉.၁၂%)
Lowest
၄၃.၀၀ US$ (+၉၃.၄၃%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Oppenheimer
Buy
Initiated
၅၀.၀၀ US$
+၁၂၄.၉%
09/23/2026
Brandon Folkes
H.C. Wainwright
Buy
Maintained
၆၀.၀၀ US$
+၁၆၉.၉%
09/21/2026
Daniel Clark
Leerink Partners
Buy
Initiated
၄၅.၀၀ US$
+၁၀၂.၄%
09/09/2026
Srikripa Devarakonda
Truist Financial
Buy
Maintained
၄၉.၀၀ US$
+၁၂၀.၄%
09/09/2026
Alexander Xenakis
Truist Financial
Buy
Initiated
၄၉.၀၀ US$
+၁၂၀.၄%
09/09/2026
Jenna Davidner
Barclays
Buy
Reiterated
၄၈.၀၀ US$
+၁၁၅.၉%
08/18/2026
David Amsellem
Piper Sandler
Hold
Reiterated
၄၃.၀၀ US$
+၉၃.၄%
08/07/2026
Serge Belanger
Needham
Buy
Maintained
၄၆.၀၀ US$
+၁၀၆.၉%
08/06/2026
Les Sulewski
Truist Financial
Buy
Maintained
-
-
05/14/2026
Unknown Analyst
Jefferies
Buy
Maintained
၅၁.၀၀ US$
+၁၂၉.၄%
03/20/2026
Last report
၂၀၂၆ ဩ ၆
Fiscal period
Q2 2026
EPS / Est. (USD)
၁.၉၂ US$ / ၁.၇၆ US$
+၈.၇၈%beat
Revenue / Est. (USD)
၁၉.၉၉ ကုဋေ / ၂၀.၁၀ ကုဋေ
-၀.၅၃%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၂၀.၉၄ ကုဋေ
၂၀.၅၄ ကုဋေ
၁၉.၃၅ ကုဋေ
၁၉.၉၉ ကုဋေ
Cost of goods sold
၂.၁၇ ကုဋေ
၂.၁၆ ကုဋေ
၂.၀၈ ကုဋေ
၂.၁၂ ကုဋေ
Cost of revenue
၂.၁၇ ကုဋေ
၂.၁၆ ကုဋေ
၂.၀၈ ကုဋေ
၂.၁၂ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၆.၅၆ ကုဋေ
၆.၆၇ ကုဋေ
၈.၆၄ ကုဋေ
၁၀.၄၄ ကုဋေ
Operating expense
၁၂.၁၀ ကုဋေ
၁၂.၂၁ ကုဋေ
၁၄.၁၈ ကုဋေ
၁၆.၇၄ ကုဋေ
Total operating expenses
၁၄.၂၇ ကုဋေ
၁၄.၃၇ ကုဋေ
၁၆.၂၆ ကုဋေ
၁၈.၈၆ ကုဋေ
Operating income
၆.၆၇ ကုဋေ
၆.၁၇ ကုဋေ
၃.၀၉ ကုဋေ
၁.၁၃ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
၄.၃၄ ကုဋေ
၂.၉၀ ကုဋေ
၁.၈၇ ကုဋေ
-၁.၃၅ ကုဋေ
EBT excluding unusual items
၄.၈၀ ကုဋေ
၄.၆၀ ကုဋေ
၁.၈၇ ကုဋေ
-၅.၉၃ သန်း
Income tax expense
၁.၁၉ ကုဋေ
၁.၂၁ ကုဋေ
၄.၂၄ သန်း
၁.၅၂ သန်း
Effective tax rate
၂၇.၄၆%
၄၁.၅၈%
၂၂.၆၅%
-၁၁.၂၃%
Other operating expenses
-
-
-
-
Net income
၃.၁၅ ကုဋေ
၁.၇၀ ကုဋေ
၁.၄၅ ကုဋေ
-၁.၅၁ ကုဋေ
Net profit margin
၁၅.၀၅%
၈.၂၆%
၇.၄၉%
-၇.၅၃%
Earnings per share
၂.၂၅
၂.၀၄
၁.၇၆
၁.၉၂
Interest and investment income
၃.၁၂ သန်း
၃.၅၆ သန်း
၃.၇၁ သန်း
၂.၂၉ သန်း
Interest expense
-၂.၁၈ ကုဋေ
-၁.၉၃ ကုဋေ
-၁.၅၉ ကုဋေ
-၁.၉၅ ကုဋေ
Net interest expenses
-၁.၈၇ ကုဋေ
-၁.၅၇ ကုဋေ
-၁.၂၂ ကုဋေ
-၁.၇၂ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၁၂.၃၂ ကုဋေ
၁၁.၈၁ ကုဋေ
၈.၆၈ ကုဋေ
၇.၆၁ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ